Published in Hepatitis Weekly, November 1st, 2004
The request submits highly relevant prior art documents not previously considered by the U.S. PTO showing that the patent claims are invalid because they lack novelty and/or were obvious at the time the priority patent application was filed. Nucleonics also believes that the claims are ambiguous and that the application fails to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly